CBER Urges Sponsors to Adopt International Standards

Drug Industry Daily
A A
CBER said it will prefer using internationally harmonized standards developed by third-party organizations — as opposed to maintaining its own — and it is urging sponsors of biologics to do the same, according to a new draft guidance.

To View This Article:

Login

Subscribe To Drug Industry Daily